Gallica Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Ahmedabad, Gujarat, India, established in 2010.
2010 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Gallica Pharmaceuticals Private Limited

Gallica Pharmaceuticals Private Limited, a active private limited company, was established on 26 August 2010 in Ahmedabad, Gujarat, India. Engaging in wholesale within the trade sector, it holds CIN: U24230GJ2010PTC062123. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Pinali Kunjal Shah (Director), Kunjal Mahendrabhai Shah (Director). Past directors included Jayneesh Devendrakumar Gandhi, Mahendrakumar Virchandbhai Shah, Kalpeshkumar Gunavantlal Shah. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 7, Maulik Appartment, Shri Rang Society Opp. Bank Of Baroda, Jainmerchant, Fateh, Pura, Ahmedabad, Gujarat, 380007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2010PTC062123

  • Registration Number

    062123

  • Incorporation Date

    26 August 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Gallica Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gallica Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gallica Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pinali Kunjal Shah Director 04 May 2012 Current
Kunjal Mahendrabhai Shah Director 04 May 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Apr 2012 Past
Pramod Abcsdd Director 23 May 2013 Past
Pramod Abcsdd Director 29 Apr 2012 Past
Pramod Abcsdd Director 20 May 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gallica Pharmaceuticals.

Gallica Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Gallica Pharmaceuticals revenue growth over time
Gallica Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gallica Pharmaceuticals?

In 2017, Gallica Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gallica Pharmaceuticals?

Unlock and access historical data on people associated with Gallica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gallica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gallica Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gallica Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Gallica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Gallica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Director Appointment

    Progress on Pinali Kunjal Shah was appointed as a Director was appointed as a Director on 04 May 2012 & has been associated with this company since 13 years 9 months . was documented.

  • Director Appointment

    Progress on Kunjal Mahendrabhai Shah was appointed as a Director was appointed as a Director on 04 May 2012 & has been associated with this company since 13 years 9 months . was documented.

  • Company Incorporation

    Gallica Pharmaceuticals Private Limited was registered on 26 Aug 2010 with Roc Ahmedabad & aged 15 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gallica Pharmaceuticals Private Limited?

The CIN of Gallica Pharmaceuticals Private Limited is U24230GJ2010PTC062123.

Where is Gallica Pharmaceuticals Private Limited headquartered?

Gallica Pharmaceuticals Private Limited is headquartered at 7, Maulik Appartment, Shri Rang Society Opp. Bank Of Baroda, Jainmerchant, Fateh, Pura, Ahmedabad, Gujarat, 380007.

When was Gallica Pharmaceuticals Private Limited incorporated?

Gallica Pharmaceuticals Private Limited was incorporated on 26 August 2010.

Who are the current directors of Gallica Pharmaceuticals Private Limited?

The current directors of Gallica Pharmaceuticals Private Limited are

What is the primary industry of Gallica Pharmaceuticals Private Limited?

The primary industry of Gallica Pharmaceuticals Private Limited is Trade.

Is Gallica Pharmaceuticals Private Limited a listed company?

Gallica Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Gallica Pharmaceuticals Private Limited?

The authorized capital of Gallica Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Gallica Pharmaceuticals Private Limited?

The compliance status of Gallica Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available